Literature DB >> 8853242

Inhibition of motility and invasion of human lung cancer cells by invasion inhibiting factor 2.

Z G Han1, W G Jiang, S Hiscox, M B Hallett, A Isoai, R E Mansel.   

Abstract

The motility and invasion of cancer cells are basic requirements for the establishment of distant metastases. In this study, we examined the effect of invasion inhibiting factor 2 (IIF2), a motility/invasion regulatory agent, on the motility, invasion, growth and basement membrane attachment of human lung cancer cells. IIF2 significantly reduced cell dissociation, colony scattering and invasion induced by the motogenic factor, HGF/SF. Western and Northern analyses showed these cells to be positive for the HGF/SF receptor c-met. These effects were blocked by an anti-IIF2 antibody. IIF2 did not affect the growth and attachment of lung cancer cells to the basement membrane. It is concluded therefore that invasion inhibiting factor 2 is an inhibitor of human lung cancer cell motility and invasion in vitro and this may bear some importance in the construction of anti-metastatic therapies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8853242     DOI: 10.1016/s0960-7404(96)80004-1

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  4 in total

Review 1.  HMGNs, DNA repair and cancer.

Authors:  Gabi Gerlitz
Journal:  Biochim Biophys Acta       Date:  2009-12-08

2.  Immunohistopathological characterizatin of spontaneous metastases in a human lung mucoepidermoid adenocarcinoma (HLMC) xenograft.

Authors:  M V Croce; A G Colussi; M G De Bravo; M R Price; A Segal-Eiras
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

3.  Prognostic and clinicopathological value of melanoma-associated antigen D4 in patients with glioma.

Authors:  Jun Yan; Jing Wen; Zong-Dang Wei; Xi-Sheng Li; Ping Li; Shao-Wen Xiao
Journal:  Oncol Lett       Date:  2018-01-26       Impact factor: 2.967

4.  Exogenous HMGN2 inhibits the migration and invasion of osteosarcoma cell lines.

Authors:  Enjie Xu; Heng Jiang; Tao Lin; Yichen Meng; Xiao Ma; Jia Yin; Jun Ma; Xuhui Zhou
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.